September 03, 2014 2:19 AM ET

Biotechnology

Company Overview of Xantos AG

Company Overview

Xantos AG, a functional biology and drug discovery company, focuses on the identification and validation of disease relevant human genes. It develops biopharmaceuticals in the areas of cancer and metabolic diseases, as well as focuses on the development of therapeutics based on secreted proteins involved in angiogenesis of cancer cells. It offers its technology, the human cDNA collections, libraries, and functional cell assay systems on a fee-for-service basis. The company’s XantoScreen robotic platform is used for various functional applications, such as molecular drug profiling, target/pathway profiling, target and protein identification, and lead identification. The XantoScreen also enabl...

Max-Lebsche-Platz 31

Munich,  81377

Germany

Founded in 1999

Phone:

49 89 899 59 400

Fax:

49 89 899 59 420

Key Executives for Xantos AG

Co-Founder and Chief Executive Officer
Age: 46
Scientific Founder and Member of Scientific Advisory Board
Chief Technology Officer
Manager of Human Resources
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Micap GmbH & Co. KG Europe
IDEA AG Europe
ACTIPAC Biosystems GmbH Europe
aminoNova AG Europe
AYOXXA Biosystems GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xantos AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.